JAK-STAT Signaling: A Double-Edged Sword of Immune Regulation and Cancer ProgressionKatie L. Owen, Belinda S. Parker|Cancers|2019Cited by 728
Neoadjuvant Interferons: Critical for Effective PD-1–Based Immunotherapy in TNBCNatasha K. Brockwell, Belinda S. Parker|Cancer Immunology Research|2017Cited by 80
Interferon-ε is a tumour suppressor and restricts ovarian cancerZoe R. C. Marks, Paul J. Hertzog, Sarah Rosli et al.|Nature|2023Cited by 70
Myoepithelial cell‐specific expression of stefin A as a suppressor of early breast cancer invasionHendrika M. Duivenvoorden, Belinda S. Parker, Jai Rautela et al.|The Journal of Pathology|2017Cited by 52
Intratumoral administration of the Toll‐like receptor 7/8 agonist 3M‐052 enhances interferon‐driven tumor immunogenicity and suppresses metastatic spread in preclinical triple‐negative breast cancerDamien Zanker, Belinda S. Parker|Clinical & Translational Immunology|2020Cited by 37